Skip Navigation

European Heart Journal 1982 3(6):516-524;
Copyright © 1982 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by WENNERBLOM, B.
Right arrow Articles by WEDEL, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WENNERBLOM, B.
Right arrow Articles by WEDEL, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1982 by The European Society of Cardiology

Antiarrhythmic efficacy and side- effects of lidocaine given in the prehospital phase of acute myocardial infarction

B. WENNERBLOM, S. HOLMBERG, L. RYDÉN* and H. WEDEL

Department of Cardiology, Medical Department I, Sahlgrenska Hospital S-413 45 Göteborg, Sweden

Received 23 February 1981; revised 18 December 1981; .

Abstract

One hundred and fifty-one patients with suspected AMI received 300 mg lidocaine i.m. or a placebo, double-blind and at random before being transported to hospital by a mobile coronary care unit. Patients with second-degree or complete AV block and sinus bradycardia (<50 beats/min) were excluded. Fifty-four patients developed myocardial infarction, while 96 had other diagnoses. The patients were kept under clinical observation, with continuous ECG registration, from the time of receiving the injection for 3 h.

The lidocaine injection significantly reduced the incidence of ventricular tachyarrhythmias in patients with myocardial infarction during the period 30–90 min after injection. No serious haemodynamic side-effects were observed. A V conduction disturbances possibly due to lidocaine were observed in three patients.

No serious side-effects of lidocaine occurred in the patients who did not develop myocardial infarction.

It is concluded that patients with suspected AMI may be given 300 mg lidocaine i.m. before transport to hospital with a low risk of serious side-effects, provided the contraindications are observed.

Key Words: Lidocaine • acute myocardial infarction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.